Development of a CD163-Targeted PET Radiotracer That Images Resident Macrophages in Atherosclerosis
Journal of Nuclear Medicine · 2024
DOI: 10.2967/jnumed.123.266910 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2024. Verfasst von Xiuli Zhang und 20 weiteren Autor:innen. Beteiligte Einrichtung: Mallinckrodt Institute of Radiology, University of Missouri, Columbia, Missouri. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Antigens, Differentiation, Myelomonocytic, Antigens, CD, Atherosclerosis. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Tissue-resident macrophages are complementary to proinflammatory macrophages to promote the progression of atherosclerosis. The noninvasive detection of their presence and dynamic variation will be important to the understanding of their role in the pathogenesis of atherosclerosis. The goal of this study was to develop a targeted PET radiotracer for imaging CD163-positive (CD163+) macrophages in multiple mouse atherosclerosis models and assess the potential of CD163 as a biomarker for atherosclerosis in humans.
Methods
CD163-binding peptide was identified using phage display and conjugated with a NODAGA chelator for 64Cu radiolabeling ([64Cu]Cu-ICT-01). CD163-overexpressing U87 cells were used to measure the binding affinity of [64Cu]Cu-ICT-01. Biodistribution studies were performed on wild-type C57BL/6 mice at multiple time points after tail vein injection. The sensitivity and specificity of [64Cu]Cu-ICT-01 in imaging CD163+ macrophages upregulated on the surface of atherosclerotic plaques were assessed in multiple mouse atherosclerosis models. Immunostaining, flow cytometry, and single-cell RNA sequencing were performed to characterize the expression of CD163 on tissue-resident macrophages. Human carotid atherosclerotic plaques were used to measure the expression of CD163+ resident macrophages and test the binding specificity of [64Cu]Cu-ICT-01. Results: [64Cu]Cu-ICT-01 showed high binding affinity to U87 cells. The biodistribution study showed rapid blood and renal clearance with low retention in all major organs at 1, 2, and 4 h after injection. In an ApoE-/- mouse model, [64Cu]Cu-ICT-01 demonstrated sensitive and specific detection of CD163+ macrophages and capability for tracking the progression of atherosclerotic lesions; these findings were further confirmed in Ldlr-/- and PCSK9 mouse models. Immunostaining showed elevated expression of CD163+ macrophages across the plaques. Flow cytometry and single-cell RNA sequencing confirmed the specific expression of CD163 on tissue-resident macrophages. Human tissue characterization demonstrated high expression of CD163+ macrophages on atherosclerotic lesions, and ex vivo autoradiography revealed specific binding of [64Cu]Cu-ICT-01 to human CD163.
Conclusion
This work reported the development of a PET radiotracer binding CD163+ macrophages. The elevated expression of CD163+ resident macrophages on human plaques indicated the potential of CD163 as a biomarker for vulnerable plaques. The sensitivity and specificity of [64Cu]Cu-ICT-01 in imaging CD163+ macrophages warrant further investigation in translational settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mallinckrodt Institute of Radiology, University of Missouri, Columbia, Missouri.
- Department of Medicine, University of Missouri, Columbia, Missouri.
- Department of Medicine, Washington University in St. Louis, St. Louis, Missouri; and.
- Department of Pathology and Immunology, Washington University in St. Louis, St. Louis, Missouri.
- Mallinckrodt Institute of Radiology, University of Missouri, Columbia, Missouri; yongjianliu@wustl.edu.
Förderung
- NHLBI NIH HHS
- NIH HHS
- NCI NIH HHS
- NIBIB NIH HHS
Zitieren
APA
Zhang, X., Heo, G. S., Li, A., Lahad, D., Detering, L., Tao, J., Gao, X., Zhang, X., Luehmann, H., Sultan, D., Lou, L., Venkatesan, R., Li, R., Zheng, J., Amrute, J., Lin, C. Y., Kopecky, B. J., Gropler, R. J., Bredemeyer, A., …, & Liu, Y. (2024). Development of a CD163-Targeted PET Radiotracer That Images Resident Macrophages in Atherosclerosis. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.123.266910
Vancouver
Zhang X, Heo GS, Li A, Lahad D, Detering L, Tao J, et al. Development of a CD163-Targeted PET Radiotracer That Images Resident Macrophages in Atherosclerosis. Journal of Nuclear Medicine. 2024. doi:10.2967/jnumed.123.266910
BibTeX
@article{Zhang2024,
author = {Zhang, Xiuli and Heo, Gyu Seong and Li, Alexandria and Lahad, Divangana and Detering, Lisa and Tao, Joan and Gao, Xuefeng and Zhang, Xiaohui and Luehmann, Hannah and Sultan, Deborah and Lou, Lanlan and Venkatesan, Rajiu and Li, Ran and Zheng, Jie and Amrute, Junedh and Lin, Chieh-Yu and Kopecky, Benjamin J and Gropler, Robert J and Bredemeyer, Andrea and Lavine, Kory and Liu, Yongjian},
title = {Development of a CD163-Targeted PET Radiotracer That Images Resident Macrophages in Atherosclerosis},
journal = {Journal of Nuclear Medicine},
year = {2024},
doi = {10.2967/jnumed.123.266910}
}
EUVIMED